BioMarin製藥BMRN
那斯達克 · USD
58.14
+0.29
(+0.50%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
BioMarin製藥BMRN
58.14
+0.29
(+0.50%)
財務數據
損益表
- 5.38
- 5.96
- 5.95
- 5.81
- 6.46
- 6.49
- 7.12
- 7.46
- 7.47
- 7.45
- 6.37
- 10.95
- -0.19
- -2.34
- 11.16
- 0.41
- 9.74
- 4.73
- 0.21
- -0.29
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 745,145 | 747,313 | 745,740 | 712,029 | 648,833 | 646,207 | 581,329 | 595,275 | 596,415 | 537,538 |
營業成本 | 151,558 | 136,139 | 188,457 | 130,459 | 125,180 | 120,722 | 113,285 | 119,159 | 126,549 | 127,290 |
營業毛利 | 593,587 | 611,174 | 557,283 | 581,570 | 523,653 | 525,485 | 468,044 | 476,116 | 469,866 | 410,248 |
營業費用 | - | - | 443,390 | - | - | 525,883 | 452,136 | 420,303 | 410,519 | 434,748 |
研發費用 | 158,731 | 173,509 | 184,901 | 183,787 | 204,987 | 206,250 | 191,314 | 177,363 | 171,846 | 172,751 |
推銷及管理費用 | 206,116 | 266,607 | 253,480 | 263,032 | 225,906 | 304,397 | 245,141 | 227,316 | 223,003 | 245,739 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 4,847 | 9,651 | 5,009 | 14,299 | 14,298 | 15,236 | 15,681 | 15,624 | 15,670 | 16,258 |
營業利益 | 223,893 | 161,407 | 113,893 | 120,452 | 88,462 | -398 | 15,908 | 55,813 | 59,347 | -24,500 |
其他收入及費用 | 17,059 | 10,809 | 23,516 | 15,258 | 30,632 | 25,823 | 29,540 | 18,752 | 1,113 | 10,568 |
利息費用 | 2,863 | 2,577 | 2,968 | 3,574 | 3,547 | 6,098 | 3,779 | 3,755 | 3,703 | 3,626 |
稅前純益 | 238,089 | 169,639 | 134,441 | 132,136 | 105,547 | 19,327 | 41,669 | 70,810 | 56,757 | -17,558 |
所得稅 | 52,403 | 44,696 | 28,361 | 24,962 | 16,885 | -1,048 | 1,291 | 14,770 | 5,905 | -17,309 |
稅後純益 | 185,686 | 124,943 | 106,080 | 107,174 | 88,662 | 20,375 | 40,378 | 56,040 | 50,852 | -249 |
基本每股稅後盈餘(元) | 0.97 | 0.66 | 0.56 | 0.56 | 0.47 | 0.11 | 0.21 | 0.30 | 0.27 | 0.00 |
稀釋每股稅後盈餘(元) | 0.95 | 0.65 | 0.55 | 0.55 | 0.46 | 0.10 | 0.21 | 0.29 | 0.27 | 0.00 |
基本平均股數(千股) | 190967.00 | 190688.00 | 190429.00 | 190114.00 | 188866.00 | 188479.00 | 188219.00 | 187948.00 | 186667.00 | 186028.00 |
稀釋平均股數(千股) | 196474.00 | 196581.00 | 197147.00 | 200505.00 | 199262.00 | 191838.00 | 191173.00 | 194998.00 | 194363.00 | 186028.00 |
還原基本每股稅後盈餘(元) | 0.97 | 0.66 | 0.56 | 0.56 | 0.47 | 0.11 | 0.21 | 0.30 | 0.27 | 0.00 |
還原稀釋每股稅後盈餘(元) | 0.95 | 0.65 | 0.55 | 0.55 | 0.46 | 0.10 | 0.21 | 0.29 | 0.27 | 0.00 |
還原基本平均股數(千股) | 190,967 | 190,688 | 190,429 | 190,114 | 188,866 | 188,479 | 188,219 | 187,948 | 186,667 | 186,028 |
還原稀釋平均股數(千股) | 196,474 | 196,581 | 197,147 | 200,505 | 199,262 | 191,838 | 191,173 | 194,998 | 194,363 | 186,028 |
EBITDA(千元) | 261,659 | 194,097 | 154,474 | 159,997 | 133,942 | 49,839 | 68,885 | 97,421 | 84,911 | 9,923 |